Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine

Mesenchymal stem cells (MSCs) derived from myelodysplastic syndromes (MDSs) have been demonstrated to accelerate the progression of MDS. However, whether the phenotype of MSCs derived from MDS (MDS-MSCs) may be reversed and serve as a potential target for the treatment of MDS remains unclear. The pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Pang, Yanbin, Geng, Suxia, Zhang, Hongyang, Lai, Peilong, Liao, Pengjun, Zeng, Lingji, Lu, Zesheng, Weng, Jianyu, Du, Xin
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781515/
https://ncbi.nlm.nih.gov/pubmed/31611955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10788
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados